Sofosbuvir CAS 1190307-88-0 Purity ≥99.0% (HPLC)
Name | Sofosbuvir |
Synonyms | GS-7977; PSI-7977 |
CAS Number | 1190307-88-0 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C22H29FN3O9P |
Molecular Weight | 529.45 |
Melting Point | 120.0~125.0℃ |
Density | 1.41 |
Solubility | Soluble in DMF, DMSO, Ethanol |
Shipping Condition | Under Ambient Temperature |
COA & MSDS | Available |
Origin | Shanghai, China |
Shelf Life | 36 Months if Stored Properly |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Crystalline Powder |
Identification | HPLC; RT |
Purity / Analysis Method | ≥99.0% (HPLC) |
E.E | ≥99.0% |
Loss on Drying | ≤1.0% |
Residue on Ignition | ≤0.20% |
Single Impurity | ≤0.50% |
Total Impurities | ≤1.0% |
Heavy Metals | ≤20ppm |
Residual Solvents | Meet the requirements of specifications |
Methanol | ≤1500ppm |
TBME | ≤2500ppm |
Dichloromethane | ≤720ppm |
Tetrahydrofuran | ≤720ppm |
Toluene | ≤60ppm |
Test Standard | Enterprise Standard |
Usage | Sofosbuvir (CAS: 1190307-88-0) in the treatment of Hepatitis C Virus (HCV) |
Package: Bottle, Aluminum foil bag, 25kg/Drum, or according to customer's requirement
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture
Sofosbuvir (CAS: 1190307-88-0) (formally labeled as PSI-797, GS-7977) is a phosphoramidate prodrug and nucleotide polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) infection. It is recommended to be used in combination with other drugs (such as velpatasvir) for the first-line treatment for HCV genotypes 1, 2, 3, 4, 5, and 6. It takes effect through acting as a nucleotide analog inhibitor, being capable of specially inhibiting the HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase.
Write your message here and send it to us